300239 东宝生物
交易中 12-20 13:32:51
资讯
新帖
简况
A股人造肉概念股异动拉升，海欣食品触及涨停，金字火腿涨超4%，东宝生物、双塔食品、国恩股份跟涨。
美港电讯 · 12-06
A股人造肉概念股异动拉升，海欣食品触及涨停，金字火腿涨超4%，东宝生物、双塔食品、国恩股份跟涨。
东宝生物：11月21日接受机构调研，投资者、内蒙古上市公司协会等多家机构参与
证券之星 · 11-22
东宝生物：11月21日接受机构调研，投资者、内蒙古上市公司协会等多家机构参与
11月13日东宝生物发布公告，其股东减持922.9万股
证券之星 · 11-13
11月13日东宝生物发布公告，其股东减持922.9万股
东宝生物（300239）股东青岛国恩科技股份有限公司质押8800万股，占总股本14.82%
证券之星 · 11-13
东宝生物（300239）股东青岛国恩科技股份有限公司质押8800万股，占总股本14.82%
东宝生物(300239.SZ)主要股东百纳盛远完成减持1.998%股份
智通财经 · 11-13
东宝生物(300239.SZ)主要股东百纳盛远完成减持1.998%股份
东宝生物（300239）2024年三季报简析：净利润减30.43%，盈利能力上升
证券之星 · 10-29
东宝生物（300239）2024年三季报简析：净利润减30.43%，盈利能力上升
东宝生物(300239.SZ)发布前三季度业绩，净利润6627万元，同比下降30.43%
智通财经 · 10-27
东宝生物(300239.SZ)发布前三季度业绩，净利润6627万元，同比下降30.43%
东宝生物(300239)9月30日股东户数2.46万户，较上期增加1.22%
证券之星 · 10-27
东宝生物(300239)9月30日股东户数2.46万户，较上期增加1.22%
图解东宝生物三季报：第三季度单季净利润同比减50.65%
证券之星 · 10-27
图解东宝生物三季报：第三季度单季净利润同比减50.65%
东宝生物(300239.SZ)股东百纳盛远合计减持1.14%股份
智通财经 · 10-18
东宝生物(300239.SZ)股东百纳盛远合计减持1.14%股份
10月16日东宝生物发生1笔大宗交易 成交金额2745.59万元
证券之星 · 10-16
10月16日东宝生物发生1笔大宗交易 成交金额2745.59万元
东宝生物（300239）9月18日主力资金净买入78.38万元
证券之星 · 09-18
东宝生物（300239）9月18日主力资金净买入78.38万元
东宝生物新提交1件商标注册申请
证券之星 · 09-12
东宝生物新提交1件商标注册申请
国恩股份最新公告：控股子公司东宝生物拟收购益青生物剩余股份
证券之星 · 09-11
国恩股份最新公告：控股子公司东宝生物拟收购益青生物剩余股份
东宝生物最新公告：拟2.32亿元收购益青生物剩余40%股份
证券之星 · 09-11
东宝生物最新公告：拟2.32亿元收购益青生物剩余40%股份
东宝生物(300239.SZ)拟2.32亿元收购益青生物剩余股份 提高运营管理效率
智通财经网 · 09-11
东宝生物(300239.SZ)拟2.32亿元收购益青生物剩余股份 提高运营管理效率
东宝生物最新公告：股东计划减持不超过2%公司股份
证券之星 · 09-03
东宝生物最新公告：股东计划减持不超过2%公司股份
东宝生物：股东计划减持不超过2%公司股份
美港电讯 · 09-03
东宝生物：股东计划减持不超过2%公司股份
东宝生物(300239.SZ)股东百纳盛远拟减持不超2%股份
智通财经 · 09-03
东宝生物(300239.SZ)股东百纳盛远拟减持不超2%股份
东宝生物新提交1件商标注册申请
证券之星 · 08-31
东宝生物新提交1件商标注册申请
加载更多
公司概况
公司名称：
包头东宝生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2011-07-06
主营业务：
包头东宝生物技术股份有限公司主要从事明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。公司主要产品及服务为TOB端业务和TOC端业务。公司曾荣获“内蒙古品牌建设标杆企业”、“全国明胶行业先进企业”、“2021年度中国明胶行业突出贡献奖”、“内蒙古老字号”、“内蒙古自治区农牧业产业化重点龙头企业”、“内蒙古自治区主席质量奖”、包头市首批百年老店等荣誉。
发行价格：
9.00
{"stockData":{"symbol":"300239","market":"SZ","secType":"STK","nameCN":"东宝生物","latestPrice":5.62,"timestamp":1734672771000,"preClose":5.53,"halted":0,"volume":6923856,"delay":0,"floatShares":590000000,"shares":594000000,"eps":0.1532,"marketStatus":"交易中","marketStatusCode":2,"change":0.09,"latestTime":"12-20 13:32:51","open":5.51,"high":5.64,"low":5.5,"amount":38577600,"amplitude":0.0253,"askPrice":5.62,"askSize":31,"bidPrice":5.61,"bidSize":181,"shortable":0,"etf":0,"ttmEps":0.1532,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734678000000},"adr":0,"adjPreClose":5.53,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":6.08,"lowLimit":4.98,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":593606491,"pbRate":1.94,"roa":"--","roe":"3.93%","epsLYR":0.202,"committee":0.252265,"marketValue":3336000000,"floatMarketCap":3314000000,"peRate":36.684073,"changeRate":0.0163,"turnoverRate":0.0117,"status":0},"requestUrl":"/m/hq/s/300239","defaultTab":"news","newsList":[{"id":"2489475061","title":"A股人造肉概念股异动拉升，海欣食品触及涨停，金字火腿涨超4%，东宝生物、双塔食品、国恩股份跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2489475061","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489475061?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:07","pubTimestamp":1733465241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002515","399300","159982","BK4212","BK0186","BYND","BK0139","BK0181","BK0070","BK0238","BK4548","BK0028","BK0114","BK0077","002481","BK0239","002702","BK0226","300239","002768","BK0220"],"gpt_icon":0},{"id":"2485574472","title":"东宝生物：11月21日接受机构调研，投资者、内蒙古上市公司协会等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2485574472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485574472?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:33","pubTimestamp":1732239205,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月21日东宝生物发布公告称公司于2024年11月21日接受机构调研，投资者 、内蒙古上市公司协会、恒泰证券参与。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200008990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0077","BK0239"],"gpt_icon":0},{"id":"2483888681","title":"11月13日东宝生物发布公告，其股东减持922.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483888681","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483888681?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:01","pubTimestamp":1731506489,"startTime":"0","endTime":"0","summary":"证券之星消息，11月13日东宝生物发布公告《东宝生物:关于持股5%以上股东权益变动比例达到1%暨提前终止减持计划的公告》，其股东海南百纳盛远科技有限公司、王军于2024年10月17日至2024年11月12日间合计减持922.9万股，占公司目前总股本的1.5547%，变动期间该股股价上涨10.89%，截止11月12日收盘报5.7元。股东增减持详情见下表：根据东宝生物2024年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300036074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0077","BK0239","BK0028"],"gpt_icon":0},{"id":"2483600061","title":"东宝生物（300239）股东青岛国恩科技股份有限公司质押8800万股，占总股本14.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483600061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483600061?lang=zh_cn&edition=full","pubTime":"2024-11-13 21:20","pubTimestamp":1731504035,"startTime":"0","endTime":"0","summary":"证券之星消息，东宝生物11月13日公开信息显示，股东青岛国恩科技股份有限公司向平安银行股份有限公司青岛分行合计质押8800.0万股，占总股本14.82%。质押详情见下表：截止本公告日，股东青岛国恩科技股份有限公司已累计质押股份8800.0万股，占其持股总数的70.0%，股东海南百纳盛远科技有限公司已累计质押股份2332.0万股，占其持股总数的60.66%。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300035829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300239"],"gpt_icon":0},{"id":"2483007721","title":"东宝生物(300239.SZ)主要股东百纳盛远完成减持1.998%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483007721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483007721?lang=zh_cn&edition=full","pubTime":"2024-11-13 21:16","pubTimestamp":1731503810,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)公告，公司持股5%以上股东海南百纳盛远科技有限公司(简称“百纳盛远”)累计减持公司股份1186万股，占总股本比例1.998%，本次减持计划提前终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300239","BK0239","BK0028","BK0077"],"gpt_icon":0},{"id":"2479746993","title":"东宝生物（300239）2024年三季报简析：净利润减30.43%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479746993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479746993?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:08","pubTimestamp":1730153313,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期东宝生物发布2024年三季报。截至本报告期末，公司营业总收入6.33亿元，同比下降13.82%，归母净利润6627.37万元，同比下降30.43%。按单季度数据看，第三季度营业总收入1.89亿元，同比下降11.75%，第三季度归母净利润1493.19万元，同比下降50.65%。本报告期东宝生物盈利能力上升，毛利率同比增幅6.32%，净利率同比增幅22.59%。去年的净利率为13.07%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900005599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239"],"gpt_icon":0},{"id":"2478153154","title":"东宝生物(300239.SZ)发布前三季度业绩，净利润6627万元，同比下降30.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478153154","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478153154?lang=zh_cn&edition=full","pubTime":"2024-10-27 17:31","pubTimestamp":1730021500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)披露2024年第三季度报告，公司前三季度实现营收6.33亿元，同比下降13.82%;归母净利润6627万元，同比下降30.43%;扣非净利润5920万元，同比下降34.05%;基本每股收益0.1116元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300239"],"gpt_icon":0},{"id":"2478585161","title":"东宝生物(300239)9月30日股东户数2.46万户，较上期增加1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478585161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478585161?lang=zh_cn&edition=full","pubTime":"2024-10-27 17:01","pubTimestamp":1730019704,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东宝生物披露，截至2024年9月30日公司股东户数为2.46万户，较6月30日增加296.0户，增幅为1.22%。在生物制品行业个股中，东宝生物股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.35万户。从股价来看，2024年6月30日至2024年9月30日，东宝生物区间涨幅为18.47%，在此期间股东户数增加296.0户，增幅为1.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700013134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0239","BK0077"],"gpt_icon":0},{"id":"2478303091","title":"图解东宝生物三季报：第三季度单季净利润同比减50.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478303091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478303091?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:41","pubTimestamp":1730018515,"startTime":"0","endTime":"0","summary":"证券之星消息，东宝生物2024年三季报显示，公司主营收入6.33亿元，同比下降13.82%；归母净利润6627.37万元，同比下降30.43%；扣非净利润5919.75万元，同比下降34.05%；其中2024年第三季度，公司单季度主营收入1.89亿元，同比下降11.75%；单季度归母净利润1493.19万元，同比下降50.65%；单季度扣非净利润1313.46万元，同比下降51.57%；负债率36.68%，投资收益-300.77万元，财务费用-370.65万元，毛利率22.62%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700012578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239"],"gpt_icon":0},{"id":"2476725387","title":"东宝生物(300239.SZ)股东百纳盛远合计减持1.14%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2476725387","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476725387?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:48","pubTimestamp":1729259316,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)发布公告，股东海南百纳盛远科技有限公司(简称“百纳盛远”)于2024年10月16日通过集中竞价方式和大宗交易方式合计减持公司股票675.20万股，占公司总股本的1.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300239","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2475937865","title":"10月16日东宝生物发生1笔大宗交易 成交金额2745.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475937865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475937865?lang=zh_cn&edition=full","pubTime":"2024-10-16 16:43","pubTimestamp":1729068202,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日东宝生物发生大宗交易，交易数据如下：大宗交易成交价格4.63元，相对当日收盘价折价9.92%，成交593万股，成交金额2745.59万元，买方营业部为中信证券股份有限公司杭州凤起路证券营业部，卖方营业部为中信建投证券股份有限公司内蒙古分公司。近三个月该股共发生2笔大宗交易，合计成交7.71万手，折价成交2笔。截至2024年10月16日收盘，东宝生物报收于5.14元，下跌0.19%，换手率1.59%，成交量9.37万手，成交额4820.71万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600025683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0077","BK0239"],"gpt_icon":0},{"id":"2468759233","title":"东宝生物（300239）9月18日主力资金净买入78.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468759233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468759233?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:20","pubTimestamp":1726644029,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月18日收盘，东宝生物报收于4.5元，上涨2.27%，换手率1.51%，成交量8.93万手，成交额3965.09万元。9月18日的资金流向数据方面，主力资金净流入78.38万元，占总成交额1.98%，游资资金净流入358.82万元，占总成交额9.05%，散户资金净流出437.19万元，占总成交额11.03%。东宝生物主营业务：明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300239"],"gpt_icon":0},{"id":"2466557248","title":"东宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2466557248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466557248?lang=zh_cn&edition=full","pubTime":"2024-09-12 13:48","pubTimestamp":1726120095,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日包头东宝生物技术股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来包头东宝生物技术股份有限公司新申请注册商标3件，截止目前公司共持有注册商标314件，另有12件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200017503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300239","BK0077"],"gpt_icon":0},{"id":"2466092407","title":"国恩股份最新公告：控股子公司东宝生物拟收购益青生物剩余股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2466092407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466092407?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:30","pubTimestamp":1726054222,"startTime":"0","endTime":"0","summary":"国恩股份公告，控股子公司东宝生物拟收购公司及德裕生物所持有的益青生物剩余964.00万股股份（占益青生物总股本的40%），交易总价款为2.32亿元。交易完成后，益青生物将成为东宝生物的全资子公司。其中，东宝生物收购公司持有的益青生物804.00万股股份，交易价款为1.935亿元；东宝生物收购德裕生物持有的益青生物160.00万股股份，交易价款为3850万元。本次交易构成关联交易。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100034809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0181","BK0220","BK0077","BK0028","BK0239","BK0186","300239","002768"],"gpt_icon":0},{"id":"2466021164","title":"东宝生物最新公告：拟2.32亿元收购益青生物剩余40%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2466021164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466021164?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:10","pubTimestamp":1726053008,"startTime":"0","endTime":"0","summary":"东宝生物公告，公司拟收购国恩股份、德裕生物所持有的益青生物剩余964.00万股股份（占益青生物总股本的40%），交易价款为2.32亿元。交易完成后，东宝生物将持有益青生物100%的股份。国恩股份和德裕生物均为公司关联法人，本次交易构成关联交易。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100033820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300239","BK0077","BK0239"],"gpt_icon":0},{"id":"2466041374","title":"东宝生物(300239.SZ)拟2.32亿元收购益青生物剩余股份 提高运营管理效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2466041374","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466041374?lang=zh_cn&edition=full","pubTime":"2024-09-11 18:59","pubTimestamp":1726052380,"startTime":"0","endTime":"0","summary":"东宝生物(300239.SZ)公告，公司现持有益青生物60%的股份，公司拟收购少数...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0077","300239","BK0028"],"gpt_icon":0},{"id":"2464790458","title":"东宝生物最新公告：股东计划减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464790458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464790458?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:49","pubTimestamp":1725360586,"startTime":"0","endTime":"0","summary":"东宝生物公告，持股7.61%的股东百纳盛远计划以集中竞价或大宗交易的方式减持其持有的公司股份不超过1187.2万股(不超过公司总股本的2%)。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300031041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300239"],"gpt_icon":0},{"id":"2464876739","title":"东宝生物：股东计划减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464876739","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464876739?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:43","pubTimestamp":1725360212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0077","BK0239","BK0028","300239"],"gpt_icon":0},{"id":"2464962876","title":"东宝生物(300239.SZ)股东百纳盛远拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464962876","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464962876?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:30","pubTimestamp":1725359424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东宝生物(300239.SZ)公告，公司持股5%以上股东百纳盛远拟以集中竞价或大宗交易的方式减持其持有的公司股份不超过1187.2万股(不超过公司总股本的2%)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","300239","BK0077","BK0239"],"gpt_icon":0},{"id":"2463726265","title":"东宝生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2463726265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463726265?lang=zh_cn&edition=full","pubTime":"2024-08-31 14:00","pubTimestamp":1725084045,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日包头东宝生物技术股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来包头东宝生物技术股份有限公司新申请注册商标2件，截止目前公司共持有注册商标314件，另有11件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100012784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300239","BK0077","BK0028","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-06","address":"内蒙古自治区包头市九原区稀土高新技术产业开发区黄河大街46号","stockEarnings":[{"period":"1week","weight":-0.0829},{"period":"1month","weight":0.0298},{"period":"3month","weight":0.2101},{"period":"6month","weight":0.0801},{"period":"1year","weight":-0.0834},{"period":"ytd","weight":-0.1085}],"companyName":"包头东宝生物技术股份有限公司","boardCode":"AI0027","perCapita":"24002股","boardName":"医药制造业","registeredCapital":"59360万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 包头东宝生物技术股份有限公司主要从事明胶和胶原蛋白及其衍生产品的研发、设计、生产、销售。公司主要产品及服务为TOB端业务和TOC端业务。公司曾荣获“内蒙古品牌建设标杆企业”、“全国明胶行业先进企业”、“2021年度中国明胶行业突出贡献奖”、“内蒙古老字号”、“内蒙古自治区农牧业产业化重点龙头企业”、“内蒙古自治区主席质量奖”、包头市首批百年老店等荣誉。","serverTime":1734672774302,"listedPrice":9,"stockholders":"24564人(较上一季度增加1.22%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东宝生物(300239)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东宝生物(300239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东宝生物,300239,东宝生物股票,东宝生物股票老虎,东宝生物股票老虎国际,东宝生物行情,东宝生物股票行情,东宝生物股价,东宝生物股市,东宝生物股票价格,东宝生物股票交易,东宝生物股票购买,东宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东宝生物(300239)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东宝生物(300239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}